AstraZeneca Innovation Hub Seeking Israeli Tech as It Broadens Search for Innovation
The Calcalist website noted “Countries, companies, and corporations are tirelessly seeking the secret for innovation. So back in 2014, we asked ourselves – could we find a better way to combine science and tech, but also financially allow small organizations to tap into the human capital and infrastructure that sits within a large pharma company?” This thinking was what led to AstraZeneca launching the BioVentureHub in partnership with the Swedish government. The hub, located in Gothenburg at the heart of one of AstraZeneca’s three strategic, global R&D centers, was launched eight years ago as an open innovation ecosystem and is based on an innovative public-private partnership model.
Click here to read the full article.